课题基金 / 基金详情

Real world Comparative Effectiveness and Safety of Dabigatran versus Warfarin

Real world Comparative Effectiveness and Safety of Dabigatran versus Warfarin
达比加群与华法林的现实世界有效性和安全性比较
批准号:
266155
负责人:
Holbrook Anne M
金额:
$8.16万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2012
资助国家:
加拿大
项目状态:
已结题
起止时间:
2012-09-01 至 2014-03-01

项目摘要

项目成果

Holbrook Anne M的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Dabigatran is the first in a series of new anticoagulants approved for atrial fibrillation (AF), which is the most common chronic heart rhythm problem in Canada and a common cause of stroke. Warfarin has been the standard anticoagulant for more than 50 ye
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Improving Medication Prescribing-Related Outcomes for Vulnerable Elderly In Transitions (IMPROVE-IT): A Pilot Randomized Trial
  • 批准号:
    401511
  • 项目类别:
    Operating Grants
  • 资助金额:
    $14.46万
  • 财政年份:
    2019
  • 负责人:
    Holbrook Anne M
  • 依托单位:
A Randomized Trial of Coordinated Anticoagulant Care At Hospital Discharge: A Medication Safety Priority
  • 批准号:
    345707
  • 项目类别:
    Operating Grants
  • 资助金额:
    $44.56万
  • 财政年份:
    2016
  • 负责人:
    Holbrook Anne M
  • 依托单位:
Electronic Tools to Improve Anticoagulant Therapy for Individuals and Populations
  • 批准号:
    271671
  • 项目类别:
    Operating Grants
  • 资助金额:
    $7.2万
  • 财政年份:
    2012
  • 负责人:
    Holbrook Anne M
  • 依托单位:
A National Electronic Network for Rapid Assessment of Drug Safety and Effectiveness
  • 批准号:
    192722
  • 项目类别:
    Operating Grants
  • 资助金额:
    $7.21万
  • 财政年份:
    2009
  • 负责人:
    Holbrook Anne M
  • 依托单位: